×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CGEM – cullinan oncology, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CGEM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
03:41 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
12/1
07:00 am
cgem
Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
Medium
Report
Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
11/24
12:08 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
High
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
11/20
11:08 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
11/20
02:10 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) was given a new $26.00 price target on by analysts at New Street Research.
Low
Report
Cullinan Therapeutics (NASDAQ:CGEM) was given a new $26.00 price target on by analysts at New Street Research.
11/20
11:04 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
11/20
07:00 am
cgem
Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics Initiate Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Zipalertinib for Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR E
Low
Report
Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics Initiate Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Zipalertinib for Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR E
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/25
05:00 pm
cgem
Form 4 Cullinan Therapeutics, For: Nov 24 Filed by: Michaelson Jennifer
Low
Report
Form 4 Cullinan Therapeutics, For: Nov 24 Filed by: Michaelson Jennifer
11/24
04:28 pm
cgem
Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer
Medium
Report
Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer
11/21
04:30 pm
cgem
Form 8-K Cullinan Therapeutics, For: Nov 18
High
Report
Form 8-K Cullinan Therapeutics, For: Nov 18
11/14
04:06 pm
cgem
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: CITADEL ADVISORS LLC
Low
Report
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: CITADEL ADVISORS LLC
11/14
02:01 pm
cgem
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: Lynx1 Capital Management LP
Low
Report
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: Lynx1 Capital Management LP
11/6
07:14 am
cgem
Form 10-Q Cullinan Therapeutics, For: Sep 30
Low
Report
Form 10-Q Cullinan Therapeutics, For: Sep 30
11/6
07:03 am
cgem
Form 8-K Cullinan Therapeutics, For: Nov 06
Low
Report
Form 8-K Cullinan Therapeutics, For: Nov 06
11/3
09:14 am
cgem
Form 8-K Cullinan Therapeutics, For: Nov 03
Medium
Report
Form 8-K Cullinan Therapeutics, For: Nov 03
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: